Claude L. Malmendier

1.3k total citations
69 papers, 976 citations indexed

About

Claude L. Malmendier is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Claude L. Malmendier has authored 69 papers receiving a total of 976 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Surgery, 26 papers in Endocrinology, Diabetes and Metabolism and 16 papers in Molecular Biology. Recurrent topics in Claude L. Malmendier's work include Diabetes, Cardiovascular Risks, and Lipoproteins (23 papers), Lipoproteins and Cardiovascular Health (17 papers) and Cancer, Lipids, and Metabolism (14 papers). Claude L. Malmendier is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (23 papers), Lipoproteins and Cardiovascular Health (17 papers) and Cancer, Lipids, and Metabolism (14 papers). Claude L. Malmendier collaborates with scholars based in Belgium, France and United States. Claude L. Malmendier's co-authors include C. Delcroix, M. Berman, T. Magot, P. Alaupovic, Philippe Lambert, Françoise Grégoire, H Bryan Brewer, Jean Christophe, F. Cantraine and Petar Alaupovic and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and American Journal of Clinical Nutrition.

In The Last Decade

Claude L. Malmendier

68 papers receiving 913 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claude L. Malmendier Belgium 18 432 380 303 163 143 69 976
Terry Langer United States 8 520 1.2× 359 0.9× 228 0.8× 172 1.1× 100 0.7× 10 946
P. Alaupovic United States 18 621 1.4× 466 1.2× 282 0.9× 208 1.3× 187 1.3× 41 1.2k
Yoshisuke Maruhama Japan 12 585 1.4× 583 1.5× 248 0.8× 148 0.9× 132 0.9× 52 1.1k
A. Gustafson Sweden 18 312 0.7× 399 1.1× 177 0.6× 120 0.7× 111 0.8× 63 881
J. Frohlich Canada 16 538 1.2× 388 1.0× 185 0.6× 177 1.1× 84 0.6× 33 887
D S Fredrickson United States 7 433 1.0× 429 1.1× 138 0.5× 253 1.6× 113 0.8× 10 912
T. Magot France 17 590 1.4× 424 1.1× 306 1.0× 181 1.1× 188 1.3× 55 1.1k
Moira A. Clay Australia 14 592 1.4× 554 1.5× 283 0.9× 180 1.1× 139 1.0× 19 1.1k
Robert H. Furman United States 18 334 0.8× 417 1.1× 260 0.9× 164 1.0× 143 1.0× 31 1.1k
Christian Lallemant France 21 703 1.6× 730 1.9× 417 1.4× 188 1.2× 156 1.1× 43 1.4k

Countries citing papers authored by Claude L. Malmendier

Since Specialization
Citations

This map shows the geographic impact of Claude L. Malmendier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claude L. Malmendier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claude L. Malmendier more than expected).

Fields of papers citing papers by Claude L. Malmendier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claude L. Malmendier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claude L. Malmendier. The network helps show where Claude L. Malmendier may publish in the future.

Co-authorship network of co-authors of Claude L. Malmendier

This figure shows the co-authorship network connecting the top 25 collaborators of Claude L. Malmendier. A scholar is included among the top collaborators of Claude L. Malmendier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claude L. Malmendier. Claude L. Malmendier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wahlen, C, B Bastens, Jean-Marie Hervé, et al.. (2001). The BioEnterics Intragastric Balloon (BIB): How to Use it. Obesity Surgery. 11(4). 524–527. 41 indexed citations
2.
Malmendier, Claude L., et al.. (1992). Receptor-dependent and -independent catabolism of low-density lipoprotein in a kindred with familial hypobetalipoproteinemia. Metabolism. 41(6). 571–577. 1 indexed citations
3.
Malmendier, Claude L., et al.. (1990). Mechanisms of Hypocholesterolemia. Advances in experimental medicine and biology. 285. 173–182. 8 indexed citations
4.
Malmendier, Claude L., et al.. (1990). Kinetics of Heterogeneous Populations of Particles. Advances in experimental medicine and biology. 285. 223–232. 1 indexed citations
5.
6.
Mebazaa, Abderraouf, et al.. (1989). Plasma lipoproteins in infantile visceral Leishmaniasis: deficiency of apolipoproteins A-I and A-II. Clinica Chimica Acta. 184(2). 181–191. 19 indexed citations
7.
Malmendier, Claude L., et al.. (1988). Metabolism of apolipoprotein C-III in normolipemic human subjects. Atherosclerosis. 69(1). 51–59. 27 indexed citations
8.
Malmendier, Claude L., et al.. (1988). Protein S and SAA: Genetics, Structure and Metabolism are they Apolipoproteins and Identical. Advances in experimental medicine and biology. 243. 203–212. 2 indexed citations
9.
Malmendier, Claude L., et al.. (1987). In vivo metabolism of apolipoprotein S in humans. Comparison with apolipoprotein A-I metabolism. Clinica Chimica Acta. 170(2-3). 169–180. 9 indexed citations
10.
Goffin, Yves, et al.. (1985). Amyloidosis of the joints: evidence that human hip capsules have a unique predisposition for amyloid of the senile systemic type.. PubMed. 3(1-2). 88–95. 14 indexed citations
11.
Vanderpas, Jean, Claude L. Malmendier, Danièle Vermeylen, et al.. (1983). P.37 Relationship between vitamin e and apolipoprotein levels in premature infants. Clinical Nutrition. 2. 75–75. 1 indexed citations
12.
Malmendier, Claude L., et al.. (1979). The effect of sialic acid removal on very low density lipoprotein. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 6(2). 144–156. 3 indexed citations
13.
Malmendier, Claude L. & M. Berman. (1978). Endogenously labeled low density lipoprotein triglyceride and apoprotein B kinetics.. Journal of Lipid Research. 19(8). 978–984. 11 indexed citations
14.
Malmendier, Claude L., et al.. (1978). A Long‐Term Study of the Efficacy of Oxandrolone in Hyperlipoproteinemias. The Journal of Clinical Pharmacology. 18(1). 42–53. 10 indexed citations
15.
Malmendier, Claude L., et al.. (1977). Influence of lyophilized total pancreas on plasma lipids and on fat absorption in cystic fibrosis.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 32(2). 115–28. 3 indexed citations
16.
Malmendier, Claude L., C. Delcroix, & M. Berman. (1974). Interrelations in the Oxidative Metabolism of Free Fatty Acids, Glucose, and Glycerol in Normal and Hyperlipemic Patients A COMPARTMENTAL MODEL. Journal of Clinical Investigation. 54(2). 461–476. 37 indexed citations
17.
Malmendier, Claude L.. (1962). TISSUE DISTRIBUTION OF C14 AFTER THE INTRAVENOUS INJECTION OF LABELED FREE FATTY ACIDS AND CHYLOMICRONS IN NEPHROTIC RATS*. Journal of Clinical Investigation. 41(1). 185–195. 26 indexed citations
18.
Malmendier, Claude L., et al.. (1960). Stop-flow analysis applied to the excretion of hemoglobin. American Journal of Physiology-Legacy Content. 199(2). 292–294. 10 indexed citations
19.
Malmendier, Claude L., et al.. (1958). [Results of tests of albumin overload practised in patients with chronic glomerulonephritis].. PubMed. 64(3). 143–8. 1 indexed citations
20.
Malmendier, Claude L., et al.. (1956). [Nephrotic syndrome after treatment with gold salts].. PubMed. 62(3). 140–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Terry Langer Breakdown of academic impact, for papers by P. Alaupovic Breakdown of academic impact, for papers by Yoshisuke Maruhama Breakdown of academic impact, for papers by A. Gustafson Breakdown of academic impact, for papers by J. Frohlich Breakdown of academic impact, for papers by D S Fredrickson Breakdown of academic impact, for papers by T. Magot Breakdown of academic impact, for papers by Moira A. Clay Breakdown of academic impact, for papers by Robert H. Furman Breakdown of academic impact, for papers by Christian Lallemant
Rankless by CCL
2026